Therapeutic Products Directorate
From LIMSWiki
Jump to navigationJump to searchThe printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Pharmaceutical Drugs Directorate (PDD), previously called the Therapeutic Products Directorate (TPD), is a Canadian federal authority that regulates small molecule pharmaceutical drugs for human use. Prior to being given market authorization, a manufacturer must present substantive scientific evidence of a product's safety, efficacy, and quality as required by the Food and Drugs Act and Regulations.[1] It is one of the ten operational directorates of the Health Products and Food Branch, a branch of Health Canada.
See also
- European Medicines Agency
- Good Manufacturing Practice
- Good clinical practice
- Informed consent
- Institutional review board
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
- Investigational product
- Investigator's Brochure
References
- ^ "Pharmaceutical Drugs Directorate". Government of Canada. May 2, 2022. Archived from the original on December 5, 2023. Retrieved February 24, 2024.
 | This Canadian government–related article is a stub. You can help Wikipedia by expanding it. |
Notes
This article is a direct transclusion of the Wikipedia article and therefore may not meet the same editing standards as LIMSwiki.
